An Empirical Study of the Prescription Pattern of Drugs for Hematological Malignancies in Japan from 2010–2014

Author:

Shibata Shoyo1,Wayama Yusuke1,Tsuyuki Ai1,Matsushita Maiko2,Chiba Koji3,Matsuki Eri45,Okamoto Shinichiro5,Suzuki Takeshi1

Affiliation:

1. Division of Basic Biological Sciences, Faculty of Pharmacy, Keio University

2. Division of Clinical Physiology and Therapeutics, Faculty of Pharmacy, Keio University

3. Laboratory of Clinical Pharmacology, Faculty of Pharmacy, Yokohama University of Pharmacy

4. Department of Medicine, Federation of National Public Service Personnel Mutual Aid Associations Tachikawa Hospital

5. Division of Hematology, Department of Medicine, Keio University School of Medicine

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Reference29 articles.

1. 1) Muramatsu N, Akiyama H. Japan: super-aging society preparing for the future. Gerontologist, 51, 425–432 (2011).

2. 2) Ministry of Health. Labour and Welfare website.: ‹http://www.mhlw.go.jp/toukei/saikin/hw/jinkou/suii09/deth8.html›, accessed 18 September, 2016.

3. 3) Kawabata-Shoda E, Masuda S, Kimura H. Anticancer drug development from traditional cytotoxic to targeted therapies: evidence of shorter drug research and development time, and shorter drug lag in Japan. J. Clin. Pharm. Ther., 37, 547–552 (2012).

4. 4) Davila ML, Bouhassira DCG, Park JH, Curran KJ, Smith EL, Pegram HJ, Brentjens R. Chimeric antigen receptors for the adoptive T cell therapy of hematologic malignancies. Int. J. Hematol., 99, 361–371 (2014).

5. 5) Patel N, Reiss U, Davidoff AM, Nathwani AC. Progress towards gene therapy for haemophilia B. Int. J. Hematol., 99, 372–376 (2014).

Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Analysis of new molecular entity trends from 2006 to 2015 in Japan;Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector;2020-06-05

2. A Comparative Study of the Market Configuration of the Japanese Pharmaceutical Market Using the Gini Coefficient and Herfindahl–Hirschman Index;Therapeutic Innovation & Regulatory Science;2020-01-27

3. Analyzing Upward Deviation of Actual vs Predicted Drug Sales in Japan for a Reasonable Drug-Pricing Policy;Therapeutic Innovation & Regulatory Science;2020-01-06

4. Analyzing Upward Deviation of Actual vs Predicted Drug Sales in Japan for a Reasonable Drug-Pricing Policy;Therapeutic Innovation & Regulatory Science;2019-07-16

5. Japan oncology market overview: Current and future perspectives;Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector;2019-05-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3